Segment Information Capital Expenditures (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2020 |
|
| Segment Reporting Information [Line Items] | |||
| Capital expenditures | $ 660 | $ 686 | $ 466 |
| Payments and Accruals to Acquire Property, Plant. and Equipment | 666 | ||
| Softgel and Oral Technologies [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Capital expenditures | 109 | 61 | 54 |
| Biologics [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Capital expenditures | 453 | 516 | 330 |
| Oral and Specialty Drug Delivery [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Capital expenditures | 57 | 64 | 55 |
| Clinical Supply Services [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Capital expenditures | 17 | 26 | 10 |
| Corporate [Member] | |||
| Segment Reporting Information [Line Items] | |||
| Capital expenditures | $ 30 | $ 19 | $ 17 |